Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Amir Hossein Alizadeh Bahmani"'
Autor:
Mehrnoosh Eskandari, Amir Hossein Alizadeh Bahmani, Heydar Ali Mardani-Fard, Iman Karimzadeh, Navid Omidifar, Payam Peymani
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background length of stay (LOS) is the time between hospital admission and discharge. LOS has an impact on hospital management and hospital care functions. Methods A descriptive, retrospective study was designed on about 27,500 inpatients be
Externí odkaz:
https://doaj.org/article/1cf5eeaeac90427db6874276dd2a5b8f
Autor:
Shahriyar Shahbazi Khamas, Amir Hossein Alizadeh Bahmani, Susanne J.H. Vijverberg, Paul Brinkman, Anke H. Maitland-van der Zee
Publikováno v:
ERJ Open Research, Vol 9, Iss 4 (2023)
Background Asthma and COPD are among the most common respiratory diseases. To improve the early detection of exacerbations and the clinical course of asthma and COPD new biomarkers are needed. The development of noninvasive metabolomics of exhaled ai
Externí odkaz:
https://doaj.org/article/48b0ec5c561d4962a89f918c9d220f0e
Autor:
Marziyeh Zare, Saba Afifi, Amir Hossein Alizadeh Bahmani, Iman Karimzadeh, Mohammad Salehi-Marzijarani, Leila Zarei, Behnam Honarvar, Sulmaz Ghahremani, Kamran B Lankarani, Ali Mohammad Sabzghabaee, Payam Peymani
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 10, Iss 2, Pp 83-89 (2021)
Objective: The purpose of this study was to document the demographic data, to assess the proportion of consumed medicines and the amounts and types of drugs available to households, and to to estimate the probable prevalence of certain diseases in th
Externí odkaz:
https://doaj.org/article/2edd99220ef3489e8bbf81763c398180
Autor:
Saba Afifi, Amir Hossein Alizadeh Bahmani, Leila Zarei, Motahareh Mahi-Birjand, Mehdi Hoorang, Marziyeh Zare, Iman Karimzadeh, Farzad Peiravian, Mahtabalsadat Mirjalili, Payam Peymani
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 10, Iss 2, Pp 59-64 (2021)
Objective: Despite growing debates about the health systems' nonmedical performance, there has not been any empirical research on nonmedical performance and patients' rights consideration as a driver of human rights in the pharmaceutical sector. This
Externí odkaz:
https://doaj.org/article/c216978d353d4858b6dea353b092a8b2
Autor:
Amir Hossein Alizadeh Bahmani, Mehdi Hoorang, Sheida Hosseini, Mehrnoosh Eskandari, Kiana Shayestehfard, Mahyar Shekoohi, Nazafarin Hatami-Mazinani, Saba Afifi, Ali Mohammad Sabzghabaee, Payam Peymani
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 9, Iss 4, Pp 175-180 (2020)
Coronavirus 19 (COVID-19) is an extremely transmittable microbial infection that has emerged in Wuhan (China) in late 2019, leading to severe acute respiratory syndrome coronavirus 2 syndrome, and caused a pandemic all over the globe. This study is a
Externí odkaz:
https://doaj.org/article/af14ec75ad8e4d08827d7ab786e41ea3
Autor:
Mehrnoosh, Eskandari, Amir Hossein, Alizadeh Bahmani, Mehdi, Hoorang, Marziyeh, Zare, Saba, Afifi, Iman, Karimzadeh, Soha, Azadi, Ali Mohammad, Sabzghabaee, Kamran B, Lankarani, Fariba, Ahmadizar, Payam, Peymani
Publikováno v:
Current Drug Safety, 18(4), 528-533. Bentham Science Publishers B.V.
Objectives: Several factors influence medication patterns. The purpose of this study was to look into the role of social determinants in the use of prescribed and non-prescribed medications in a population-based setting of people over 18 in a souther
Autor:
Amir Hossein, Alizadeh Bahmani, Mahmoud I, Abdel-Aziz, Anke H, Maitland-van der Zee, Susanne J H, Vijverberg
Publikováno v:
Expert Review of Clinical Pharmacology. 15:1165-1176
Introduction: Childhood asthma is a complex heterogenous inflammatory disease that can pose a large burden on patients and their caregivers. There is a strong need to adapt asthma treatment to the individual patient taking into account underlying inf
Autor:
Amir Hossein Alizadeh Bahmani, Elise M.A. Slob, Lizan D. Bloemsma, Susanne Brandstetter, Paula Corcuera-Elosegui, Mario Gorenjak, Susanne Harner, Simone Hashimoto, Anna M. Hedman, Michael Kabesch, Gerard H. Koppelman, Javier Korta-Murua, Aletta D. Kraneveld, Anne H. Neerincx, Mariëlle W. Pijnenburg, Maria Pino-Yanes, Uroš Potočnik, Olaia Sardón-Prado, Susanne J.H. Vijverberg, Christine Wolff, Mahmoud I. Abdel-Aziz, Anke H. Maitland-van der Zee
Publikováno v:
European journal of pharmaceutical sciences, 181:106360. Elsevier
European Journal of Pharmaceutical Sciences, 181:106360. ELSEVIER SCIENCE BV
European Journal of Pharmaceutical Sciences, 181:106360. Elsevier
European Journal of Pharmaceutical Sciences, 181:106360. ELSEVIER SCIENCE BV
European Journal of Pharmaceutical Sciences, 181:106360. Elsevier
BACKGROUND: Uncontrolled pediatric asthma has a large impact on patients and their caregivers. More insight into determinants of uncontrolled asthma is needed. We aim to compare treatment regimens, inhaler techniques, medication adherence and other c
Autor:
Sulmaz Ghahremani, Iman Karimzadeh, Saba Afifi, Payam Peymani, Leila Zarei, Behnam Honarvar, Marziyeh Zare, Ali Mohammad Sabzghabaee, Mohammad Salehi-Marzijarani, Amir Hossein Alizadeh Bahmani, Kamran Bagheri Lankarani
Publikováno v:
Journal of Research in Pharmacy Practice
Journal of Research in Pharmacy Practice, Vol 10, Iss 2, Pp 83-89 (2021)
Journal of Research in Pharmacy Practice, Vol 10, Iss 2, Pp 83-89 (2021)
Objective: The purpose of this study was to document the demographic data, to assess the proportion of consumed medicines and the amounts and types of drugs available to households, and to to estimate the probable prevalence of certain diseases in th
Autor:
Mehdi Hoorang, Saba Afifi, Amir Hossein Alizadeh Bahmani, Mahtabalsadat Mirjalili, Leila Zarei, Farzad Peiravian, Motahareh Mahi-Birjand, Marziyeh Zare, Iman Karimzadeh, Payam Peymani
Publikováno v:
Journal of Research in Pharmacy Practice
Journal of Research in Pharmacy Practice, Vol 10, Iss 2, Pp 59-64 (2021)
Journal of Research in Pharmacy Practice, Vol 10, Iss 2, Pp 59-64 (2021)
Objective: Despite growing debates about the health systems' nonmedical performance, there has not been any empirical research on nonmedical performance and patients' rights consideration as a driver of human rights in the pharmaceutical sector. This